<p><i>IGHV</i> mutational status homology ≥ 98%: M, mutated; UM, unmutated. ZAP70 is considered negative when the ratio (<i>R</i>) of mean fluorescence of T lymphocytes/mean fluorescence of CLL B lymphocytes ≥ 12. ZAP70 is considered positive if <i>R</i> ≤ 10, and “grey zone” if 10 < <i>R</i> < 12. CD38 is considered positive when the percentage of positive leukemic cells is ≥30%. FISH: score of interphasic cells with an abnormality. Complex karyotype is ≥3 chromosomal abnormalities. bi, biallelic; Del, deletion; mono, monoallelic; nd, not done.</p><p>Features of CLL patients with clinical Binet Stage B/C.</p
Chronic lymphocytic leukemia (CLL) displays remarkable clinical heterogeneity, likely attributed to ...
PURPOSE: To investigate the incidence and clinical relevance of classic and new prognostic markers, ...
The arbitrary cut-off of 5000/\ub5L chronic lymphocytic leukemia (CLL)-phenotype cells in peripheral...
<p><i>IGHV</i> mutational status homology ≥ 98%: M, mutated; UM, unmutated. ZAP70 is considered nega...
Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires parameters to ...
Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires parameters to ...
Background. Biologic risk factors such as immunoglobulin variable heavy chain (IgVH) gene mutation s...
The diagnosis of chronic lymphocytic leukaemia (CLL) is based on clinical and laboratory features. M...
Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the B cells of the immune system...
The clinical course of chronic lymphocytic leukemia (CLL) is extremely heterogeneous and while some ...
Background. Chronic lymphocytic leukemia (CLL) is a disease with a high variability in clinical pres...
a<p>Clinical stage according to references <a href="http://www.plosone.org/article/info:doi/10.1371/...
Background. Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease. Adverse progno...
In chronic lymphocytic leukaemia (CLL), caution is warranted regarding the clinical implications of ...
We describe the clinical-biological features of 63 cases of variant B chronic lymphocytic leukemia (...
Chronic lymphocytic leukemia (CLL) displays remarkable clinical heterogeneity, likely attributed to ...
PURPOSE: To investigate the incidence and clinical relevance of classic and new prognostic markers, ...
The arbitrary cut-off of 5000/\ub5L chronic lymphocytic leukemia (CLL)-phenotype cells in peripheral...
<p><i>IGHV</i> mutational status homology ≥ 98%: M, mutated; UM, unmutated. ZAP70 is considered nega...
Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires parameters to ...
Background. The clinical heterogeneity of chronic lymphocytic leukemia (CLL) requires parameters to ...
Background. Biologic risk factors such as immunoglobulin variable heavy chain (IgVH) gene mutation s...
The diagnosis of chronic lymphocytic leukaemia (CLL) is based on clinical and laboratory features. M...
Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the B cells of the immune system...
The clinical course of chronic lymphocytic leukemia (CLL) is extremely heterogeneous and while some ...
Background. Chronic lymphocytic leukemia (CLL) is a disease with a high variability in clinical pres...
a<p>Clinical stage according to references <a href="http://www.plosone.org/article/info:doi/10.1371/...
Background. Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease. Adverse progno...
In chronic lymphocytic leukaemia (CLL), caution is warranted regarding the clinical implications of ...
We describe the clinical-biological features of 63 cases of variant B chronic lymphocytic leukemia (...
Chronic lymphocytic leukemia (CLL) displays remarkable clinical heterogeneity, likely attributed to ...
PURPOSE: To investigate the incidence and clinical relevance of classic and new prognostic markers, ...
The arbitrary cut-off of 5000/\ub5L chronic lymphocytic leukemia (CLL)-phenotype cells in peripheral...